Cessatech A/S Logo

Cessatech A/S

CESSA | SPGR

Overview

Corporate Details

ISIN(s):
DK0061411964
LEI:
549300WO5SKVXWPOXR16
Country:
Denmark
Address:
Kanonbådsvej 2, 1437 København K
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Cessatech A/S is a clinical-stage pharmaceutical company specializing in the research and development of pain relief treatments for children. A spinout from Copenhagen University Hospital, Rigshospitalet, the company focuses on addressing unmet medical needs in pediatric care. Its lead asset, CT001, is a non-invasive analgesic nasal spray designed for children aged 1-17 experiencing acute pain or pain related to medical procedures. Cessatech's business model involves identifying and developing drugs with proven efficacy in adults for pediatric applications, aiming for a potentially shorter and de-risked development pathway. The company is managed by a team with extensive experience in drug development, pediatric research, and product launches.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Cessatech A/S. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cessatech A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cessatech A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Initiator Pharma A/S Logo
Clinical-stage firm developing drugs for nervous system disorders like ED & trigeminal neuralgia.
Denmark INIT
Innate Pharma Logo
Clinical-stage biotech developing antibodies that harness NK cells to fight cancer.
France IPH
IntegraGen Logo
Genomics specialist providing analyses & SaaS for cancer/rare diseases to researchers & labs.
France ALINT
Inventiva Logo
Develops oral small molecule therapies for fibrosis, oncology, and lysosomal storage disorders.
France IVA
IRLAB Therapeutics Logo
Developing novel treatments for neurodegenerative conditions like Parkinson's disease.
Sweden IRLAB
Isofol Medical Logo
Clinical-stage biotech developing a drug to enhance chemotherapy efficacy for colorectal cancer.
Sweden ISOFOL
IXICO PLC Logo
AI-powered neuroimaging and biomarker analytics for neurological clinical trials.
United Kingdom IXI
J. Molner AS Logo
A CDRO specializing in generic injectable and topical drugs for the North American market.
Estonia JML
Kadimastem Ltd. Logo
Develops off-the-shelf cell therapies for neurodegenerative and metabolic diseases.
Israel KDST
Kancera Logo
Develops drugs targeting the fractalkine axis for severe inflammation and resistant cancers.
Sweden KAN